A study to investigate the use of degarelix and GnRH agonists, and to compare cardiovascular events following initiation of therapy
Latest Information Update: 24 Aug 2021
At a glance
- Drugs Degarelix (Primary) ; Goserelin; Leuprorelin; Triptorelin
- Indications Prostate cancer
- Focus Adverse reactions
Most Recent Events
- 26 Jun 2020 New trial record
- 18 May 2020 Results presented at the 115th Annual Meeting of the American Urological Association